List of withdrawn drugs

From DrugPedia: A Wikipedia for Drug discovery

(Difference between revisions)
Jump to: navigation, search
Current revision (05:54, 21 August 2008) (edit) (undo)
 
Line 1: Line 1:
 +
{{Refimprove|date=August 2008}}
Some drugs have been withdrawn from the market because of risks to the patients. Usually this has been prompted by unexpected adverse effects that were not detected during Phase III clinical trials and were only apparent from postmarketing surveillance data from the wider patient community.
Some drugs have been withdrawn from the market because of risks to the patients. Usually this has been prompted by unexpected adverse effects that were not detected during Phase III clinical trials and were only apparent from postmarketing surveillance data from the wider patient community.
   
   

Current revision

Some drugs have been withdrawn from the market because of risks to the patients. Usually this has been prompted by unexpected adverse effects that were not detected during Phase III clinical trials and were only apparent from postmarketing surveillance data from the wider patient community.

Thalidomide


Lysergic acid diethylamide (LSD)


Diethylstilbestrol


Phenformin and Buformin


Ticrynafen


Zimelidine


Methaqualone


Triazolam


Temafloxacin


Alpidem (Ananxyl)


Fen-phen


Trovafloxacin (Trovan)


cerivastatin